← 產業報告目錄

Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diagnostic Center) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-05-01頁數 326報告編號 HIT2128

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The VNA & PACS market is projected to reach USD 8.57 billion by 2031 from USD 5.60 billion in 2026, at a CAGR of 8.9%. The VNA & PACS market is seeing an increase in demand due to the evolution in the delivery of healthcare services, in which providers need imaging platforms that help coordinate care in hospitals, clinics, and diagnostic facilities. The adoption of a data-centric healthcare model has increased the demand for imaging records, which would allow clinicians to gain access to patients’ medical history and help with diagnosis and treatment plans. In addition to this, there is a demand for outpatient imaging centers, which need cloud-based PACS and VNA systems to support their imaging processes. Also, the rise in the adoption of software as a service (SaaS) business models by vendors has influenced the strategies of providers who look for flexible options and less expensive total cost of ownership models. This demand is further supported by the recent mergers and acquisitions in the industry, such as Intelerad Medical Systems Incorporated (Canada) acquired by GE HealthCare (US) in March 2026. “By product type, the VNA segment accounted for the largest share of the VNA & PACS market in 2025.” By type of product, the VNA category will dominate the VNA & PACS market in 2025 since it provides healthcare institutions with the ability to centrally manage imaging data and ensure the sustainability of their IT infrastructure through interoperability among different systems. Through VNAs, healthcare providers can separate their data from their proprietary PACS and allow for easy information exchange without compromising system dependency issues. As stated by the Healthcare Information and Management Systems Society (2023), health facilities are shifting towards an enterprise imaging approach that stresses interoperable and vendor-neutral infrastructure to promote better patient care and improve the accessibility of their information. Similarly, according to the European Society of Radiology, long-term archiving of images and cross-enterprise data exchange have become fundamental in radiology practices today. Recent industry trends indicate that Hyland Software, Inc. (US) is developing its cloud-based VNA solution in 2025 to meet the demands of large-scale enterprises. “By vendor type, the third-party vendor segment is expected to have the fastest growth during the forecast period.” Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. The third-party vendor market is projected to experience the highest rate of growth during the forecasted period, mainly owing to the growing demand for interoperability among different healthcare IT environments. Third-party vendors are involved in offering solutions that ensure interoperability among PACS, VNA, EHR, and various other clinical software applications so that healthcare organizations are able to integrate all of their data while maintaining their current infrastructure. As stated in a study conducted by Radsource in January 2025, PACS interoperability helps healthcare institutions become more efficient in the workflow process and improve overall patient care by exchanging data with other health systems. A recent development that shows the importance of PACS interoperability involves the enhancement of interoperable data management solutions by BridgeHead Software Ltd. (UK) and PaxeraHealth Corp. (US). “APAC will witness the highest growth rate during the forecast period.” The VNA & PACS Market in the Asia Pacific region is witnessing robust growth due to increased spending on healthcare infrastructure, swift digitization of hospitals, and the escalating need for imaging diagnostics in a large number of patients. The governments in the region are aggressively implementing digital health strategies at the national level to facilitate better data exchange and accessibility. As per the report published by the World Health Organization (2021), nations in the Asia Pacific region are fast-tracking their digital health technology adoption to optimize the efficiency and delivery of services in health systems. Furthermore, the development of hospital chains and increased usage of electronic medical records are driving a high demand for comprehensive imaging data management systems. For example, FUJIFILM Holdings Corporation (Japan) is expanding its enterprise imaging solutions in Asia Pacific in 2025, whereas Canon Medical Systems Corporation (Japan) upgraded its imaging informatics offerings in 2025. The breakdown of primary participants is as given below: • By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25% • By Designation - C-level: 42%, Director-level: 31%, and Others: 27% • By Region - North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 6%, Middle East & Africa: 5% Agfa-Gevaert Group (Belgium) and Canon Medical Systems Corporation (Japan) are some of the key players in the VNA PACS market. • The study includes an in-depth competitive analysis of these key players in the VNA PACS market, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the VNA & PACS Market by Product Type (VNA [Department VNA, Multi-Department VNA, Multi-Site VNA], PACS [Department PACS, Multi-Department PACS, Multi-Site PACS]) | VNA & PACS Market, by Modality (CT, Mammography, MRI, Ultrasound, X-Rays, PET) | VNA & PACS Market, by Deployment (On-Premise Deployment, Cloud-Based Deployment, Hybrid Deployment) | VNA & PACS Market, by Vendor Type (Independent Vendor, Third-Party Vendor) | VNA & PACS Market, by Application (Cardiology, Orthopedic, Oncology, Neurology, Obstetrics and Gynecology, Other Applications) | VNA & PACS Market, by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Other End Users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the VNA PACS market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the VNA PACS market. Competitive analysis of upcoming startups in the VNA PACS market ecosystem is covered in this report. Reasons to buy this report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the VNA & PACS market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (Heightened investments in medical imaging technologies, Growing demand for streamlined healthcare data management solutions, Integration of PACS/VNA with electronic medical records) restraints (High initial investment for implementing VNA and PACS solutions, Lack of standardized protocols and interoperability frameworks) opportunities (InFavorable government initiatives for better penetration of Al in medical imaging, Increasing medical imaging procedures and large imaging data silos, Rapid uptake of big data in healthcare) challenges (Rising security concerns related to cloud-based image processing and analytics, Data security issues in healthcare settings) influencing the growth of the VNA PACS market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the VNA & PACS Market • Market Development: Comprehensive information about lucrative markets; the report analyses the VNA PACS market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the VNA & PACS Market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like FUJIFILM Holdings Corporation (Japan), GE HealthCare (US), Merative (US), Sectra AB (Sweden), Siemens Healthineers AG (Germany), BridgeHead Software Ltd. (UK), among others, in the VNA PACS market
目錄 Table of Contents
1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 STUDY SCOPE 30 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 30 1.3.2 INCLUSIONS AND EXCLUSIONS 31 1.3.3 YEARS CONSIDERED 32 1.4 CURRENCY CONSIDERED 32 1.5 STAKEHOLDERS 33 2 EXECUTIVE SUMMARY 34 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 34 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 35 2.3 DISRUPTIVE TRENDS SHAPING VNA & PACS MARKET 36 2.4 HIGH-GROWTH SEGMENTS 37 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38 3 PREMIUM INSIGHTS 39 3.1 ATTRACTIVE OPPORTUNITIES FOR VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 39 3.2 NORTH AMERICA VNA PACS MARKET, BY END USER AND COUNTRY 40 3.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY 41 4 MARKET OVERVIEW 42 4.1 INTRODUCTION 42 4.2 MARKET DYNAMICS 42 4.2.1 DRIVERS 43 4.2.1.1 Heightened investments in medical imaging technologies 43 4.2.1.2 Growing demand for streamlined healthcare data management solutions 43 4.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs) 44 4.2.2 RESTRAINTS 45 4.2.2.1 High initial investment 45 4.2.2.2 Lack of standardized protocols and interoperability frameworks 45 4.2.3 OPPORTUNITIES 46 4.2.3.1 Government initiatives to increase penetration of AI in medical imaging 46 4.2.3.2 Increasing medical imaging procedures and large imaging data silos 47 4.2.3.3 Rapid uptake of big data in healthcare 47   4.2.4 CHALLENGES 48 4.2.4.1 Rising security concerns related to cloud-based image processing and analytics 48 4.2.4.2 Data security issues 49 4.3 UNMET NEEDS AND WHITE SPACES 49 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 50 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 50 5 INDUSTRY TRENDS 52 5.1 PORTER’S FIVE FORCES ANALYSIS 52 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 53 5.1.2 BARGAINING POWER OF SUPPLIERS 53 5.1.3 BARGAINING POWER OF BUYERS 53 5.1.4 THREAT OF NEW ENTRANTS 53 5.1.5 THREAT OF SUBSTITUTES 54 5.2 MACROECONOMICS INDICATORS 54 5.2.1 INTRODUCTION 54 5.2.2 GDP TRENDS AND FORECAST 54 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 54 5.3 VALUE CHAIN ANALYSIS 54 5.4 ECOSYSTEM MAPPING 56 5.5 PRICING ANALYSIS 59 5.5.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS, BY PRODUCT TYPE 59 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 60 5.6 KEY CONFERENCES AND EVENTS, 2026–2027 60 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 61 5.8 INVESTMENT AND FUNDING SCENARIO 61 5.9 CASE STUDY ANALYSIS 62 5.9.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM 62 5.9.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA 63 5.10 IMPACT OF 2025 US TARIFF OVERVIEW 63 5.10.1 INTRODUCTION 63 5.10.2 KEY TARIFF RATES 63 5.10.3 PRICE IMPACT ANALYSIS 64 5.11 IMPACT ON COUNTRY/REGION 64 5.11.1 THE US 64 5.11.2 EUROPE 64 5.11.3 APAC 65   5.12 IMPACT ON END USE INDUSTRIES 65 5.13 CONCLUSION 66 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 67 6.1 KEY EMERGING TECHNOLOGIES 67 6.1.1 DICOM (DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE) 67 6.1.2 ENTERPRISE IMAGING SOLUTIONS 67 6.1.3 CLOUD-BASED STORAGE AND SERVICES 67 6.2 COMPLEMENTARY TECHNOLOGIES 67 6.2.1 IMAGE EXCHANGE NETWORKS 67 6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE 67 6.3 ADJACENT TECHNOLOGIES 68 6.3.1 HEALTH INFORMATION EXCHANGE (HIE) 68 6.4 PATENT ANALYSIS 68 6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 68 6.5 FUTURE APPLICATIONS 70 6.5.1 AI-ENABLED ENTERPRISE DIAGNOSTIC ORCHESTRATION 70 6.5.2 MULTI-SPECIALTY ENTERPRISE IMAGING REPOSITORY 71 6.5.3 IMAGING DATA LAKE FOR CLINICAL RESEARCH AND REAL-WORLD EVIDENCE 71 6.5.4 CLOUD-BASED REGIONAL IMAGE EXCHANGE AND VIRTUAL CARE NETWORKS 71 6.5.5 PERSONALIZED AND LONGITUDINAL IMAGING INTELLIGENCE 72 7 REGULATORY LANDSCAPE 73 7.1 REGIONAL REGULATIONS AND COMPLIANCE 73 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 7.1.2 REGULATIONS 75 7.1.2.1 US 75 7.1.2.2 Europe 75 7.1.2.3 China 76 7.1.2.4 Japan 76 7.1.2.5 India 76 7.1.3 INDUSTRY STANDARDS 76 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 77 8.1 INTRODUCTION 77 8.2 DECISION-MAKING PROCESS 77 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 77 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 77 8.3.2 BUYING CRITERIA 78   8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 79 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 80 8.5.1 UNMET NEEDS 80 8.5.2 END-USER EXPECTATIONS 81 8.6 MARKET PROFITABILITY 82 9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE 83 9.1 INTRODUCTION 84 9.2 VNA 84 9.2.1 DEPARTMENT VNA 86 9.2.1.1 Phased imaging modernization driving VNA adoption and interoperability growth 86 9.2.2 MULTI-DEPARTMENT VNA 87 9.2.2.1 Cross-department imaging consolidation driving scalable enterprise data platform adoption 87 9.2.3 MULTI-SITE VNA 89 9.2.3.1 Cloud-based multi-site imaging consolidation enabling scalable, centralized care delivery 89 9.3 PACS 90 9.3.1 DEPARTMENT PACS 92 9.3.1.1 Rising imaging volumes and workforce shortages driving workflow-centric PACS adoption 92 9.3.2 MULTI-DEPARTMENT PACS 93 9.3.2.1 Shared imaging platforms reducing silos and enabling cross-specialty collaboration 93 9.3.3 MULTI-SITE PACS 95 9.3.3.1 Centralized cloud PACS enabling cross-site workload balancing and productivity gains 95 10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY 97 10.1 INTRODUCTION 98 10.2 CT 98 10.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH 98 10.3 MAMMOGRAPHY 100 10.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH 100 10.4 ULTRASOUND 101 10.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH 101 10.5 MAGNETIC RESONANCE IMAGING (MRI) 103 10.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET 103 10.6 X-RAY 104 10.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET 104   10.7 PET 106 10.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET 106 11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL 108 11.1 INTRODUCTION 109 11.2 ON-PREMISE MODEL 109 11.2.1 ON-PREMISE DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA 109 11.3 CLOUD-BASED MODEL 111 11.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL’S POPULARITY 111 11.4 HYBRID MODEL 112 11.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS 112 12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE 114 12.1 INTRODUCTION 115 12.2 INDEPENDENT VENDOR 115 12.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE 115 12.3 THIRD-PARTY VENDOR 117 12.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS’ PRESENCE IN MARKET 117 13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION 119 13.1 INTRODUCTION 120 13.2 CARDIOLOGY 120 13.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET 120 13.3 ORTHOPEDIC 122 13.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH 122 13.4 ONCOLOGY 123 13.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY 123 13.5 NEUROLOGY 125 13.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH 125 13.6 OBSTETRICS & GYNECOLOGY 126 13.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS 126 13.7 OTHER APPLICATIONS 128   14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER 130 14.1 INTRODUCTION 131 14.2 HOSPITALS & CLINICS 131 14.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS 131 14.3 DIAGNOSTIC CENTERS 133 14.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS 133 14.4 AMBULATORY SURGERY CENTERS 134 14.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS 134 14.5 OTHER END USERS 136 15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION 138 15.1 INTRODUCTION 139 15.2 NORTH AMERICA 139 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144 15.2.2 US 144 15.2.2.1 Regulatory Interoperability Mandates and Cloud-First Enterprise Imaging Strategies 144 15.2.3 CANADA 148 15.2.3.1 Pan-Canadian Interoperability Drive Opens Enterprise Imaging Investment Pipeline 148 15.3 EUROPE 153 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157 15.3.2 GERMANY 157 15.3.2.1 Hospital Future Act Investment Cycle Accelerates PACS and VNA Modernization 157 15.3.3 UK 160 15.3.3.1 NHS Digital Diagnostic Programme and AI Mandate Catalyze GBP 700M Imaging IT Overhaul 160 15.3.4 FRANCE 165 15.3.4.1 Ségur du Numérique Imaging Wave Drives RIS-PACS Interoperability at National Scale 165 15.3.5 ITALY 168 15.3.5.1 PNRR-Funded Hospital Modernization Drives PACS Replacement and Digital Imaging Upgrades 168 15.3.6 SPAIN 172 15.3.6.1 National Health System Digitization and Regional Imaging Network Expansion Drive Market Growth 172 15.3.7 REST OF EUROPE 176   15.4 ASIA PACIFIC 181 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 184 15.4.2 JAPAN 185 15.4.2.1 Aging Society and Society 5.0 Strategy Drive Next-Generation PACS Replacement Cycle 185 15.4.3 CHINA 189 15.4.3.1 Healthy China 2030 and 14th Five-Year Plan Drive National EMR and Imaging Informatization 189 15.4.4 INDIA 194 15.4.4.1 Ayushman Bharat Digital Mission Creates National Imaging Data Infrastructure Demand 194 15.4.5 REST OF ASIA PACIFIC 197 15.5 LATIN AMERICA 202 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 205 15.5.2 BRAZIL 206 15.5.2.1 SUS Hospital Modernization and Private Sector AI Imaging Adoption Drive Regional Market Leadership 206 15.5.3 MEXICO 209 15.5.3.1 Private Hospital Expansion and Public Sector Technology Modernization Open PACS Growth Pathway 209 15.5.4 REST OF LATIN AMERICA 213 15.6 MIDDLE EAST & AFRICA 218 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 222 15.6.2 GCC COUNTRIES 222 15.6.2.1 Vision 2030 and National Health Digitization Investments Accelerate Smart Hospital Imaging Deployments 222 15.6.3 REST OF MIDDLE EAST & AFRICA 226 16 COMPETITIVE LANDSCAPE 231 16.1 OVERVIEW 231 16.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 231 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 232 16.3 REVENUE SHARE ANALYSIS 234 16.4 MARKET SHARE ANALYSIS, 2025 234 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 237 16.5.1 STARS 237 16.5.2 EMERGING LEADERS 237 16.5.3 PERVASIVE PLAYERS 237 16.5.4 PARTICIPANTS 238 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 239 16.5.5.1 Company footprint 239 16.5.5.2 Product footprint 240 16.5.5.3 Deployment footprint 240 16.5.5.4 End user footprint 241 16.5.5.5 Regional footprint 242 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 243 16.6.1 PROGRESSIVE COMPANIES 243 16.6.2 RESPONSIVE COMPANIES 243 16.6.3 DYNAMIC COMPANIES 243 16.6.4 STARTING BLOCKS 243 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 245 16.6.5.1 Detailed list of key startups/SMEs 245 16.7 COMPANY VALUATION AND FINANCIAL METRICS 246 16.8 BRAND/SOFTWARE COMPARISON 247 16.9 COMPETITIVE SCENARIO 248 16.9.1 PRODUCT LAUNCHES & UPGRADES 248 16.9.2 DEALS 249 16.9.3 OTHER DEVELOPMENTS 250 17 COMPANY PROFILES 251 17.1 KEY COMPANIES 251 17.1.1 AGFA-GEVAERT GROUP 251 17.1.1.1 Business overview 251 17.1.1.2 Solutions offered 252 17.1.1.3 Recent developments 253 17.1.1.3.1 Deals 253 17.1.1.4 MnM view 254 17.1.1.4.1 Right to win 254 17.1.1.4.2 Strategic choices 254 17.1.1.4.3 Weaknesses & competitive threats 254 17.1.2 FUJIFILM HOLDINGS CORPORATION 255 17.1.2.1 Business overview 255 17.1.2.2 Solutions offered 256 17.1.2.3 Recent developments 257 17.1.2.3.1 Deals 257 17.1.2.3.2 Other developments 258 17.1.2.4 MnM view 258 17.1.2.4.1 Right to win 258 17.1.2.4.2 Strategic choices 258 17.1.2.4.3 Weaknesses & competitive threats 258   17.1.3 SECTRA AB 259 17.1.3.1 Business overview 259 17.1.3.2 Solutions offered 260 17.1.3.3 MnM view 261 17.1.3.3.1 Right to win 261 17.1.3.3.2 Strategic choices 261 17.1.3.3.3 Weaknesses & competitive threats 262 17.1.4 GE HEALTHCARE 263 17.1.4.1 Business overview 263 17.1.4.2 Solutions offered 264 17.1.4.3 Recent developments 265 17.1.4.3.1 Product launches 265 17.1.4.3.2 Deals 266 17.1.4.4 MnM view 266 17.1.4.4.1 Right to win 266 17.1.4.4.2 Strategic choices 267 17.1.4.4.3 Weaknesses & competitive threats 267 17.1.5 MERATIVE 268 17.1.5.1 Business overview 268 17.1.5.2 Solutions offered 268 17.1.5.3 Recent developments 269 17.1.5.3.1 Deals 269 17.1.5.4 MnM view 270 17.1.5.4.1 Key strengths 270 17.1.5.4.2 Strategic choices 270 17.1.5.4.3 Weaknesses & competitive threats 270 17.1.6 KONINKLIJKE PHILIPS N.V. 271 17.1.6.1 Business overview 271 17.1.6.2 Solutions offered 272 17.1.6.3 Recent developments 273 17.1.6.3.1 Product launches 273 17.1.6.3.2 Deals 274 17.1.7 CANON MEDICAL SYSTEMS CORPORATION 275 17.1.7.1 Business overview 275 17.1.7.2 Solutions offered 276 17.1.7.3 Recent developments 277 17.1.7.3.1 Deals 277 17.1.8 PAXERAHEALTH 278 17.1.8.1 Business overview 278 17.1.8.2 Solutions offered 278   17.1.9 NOVARAD CORPORATION 280 17.1.9.1 Business overview 280 17.1.9.2 Solutions offered 280 17.1.10 HYLAND SOFTWARE, INC. 282 17.1.10.1 Business overview 282 17.1.10.2 Solutions offered 282 17.1.10.3 Recent developments 283 17.1.10.3.1 Deals 283 17.1.11 SIEMENS HEALTHCARE LIMITED 284 17.1.11.1 Business overview 284 17.1.11.2 Solutions offered 285 17.1.11.3 Recent developments 286 17.1.11.3.1 Deals 286 17.1.12 BRIDGEHEAD SOFTWARE LTD. 287 17.1.12.1 Business overview 287 17.1.12.2 Solutions offered 287 17.1.13 CANOPY PARTNERS 288 17.1.13.1 Business overview 288 17.1.13.2 Solutions offered 288 17.1.14 CRELIOHEALTH INC. 289 17.1.14.1 Business overview 289 17.1.14.2 Solutions offered 289 17.1.15 ASPYRA, LLC 290 17.1.15.1 Business overview 290 17.1.15.2 Solutions offered 290 17.1.16 POSTDICOM 292 17.1.16.1 Business overview 292 17.1.16.2 Solutions offered 292 17.1.17 MEDICASOFT 294 17.1.17.1 Business overview 294 17.1.17.2 Solutions offered 294 17.1.18 ESAOTE SPA 295 17.1.18.1 Business overview 295 17.1.18.2 Solutions offered 295 17.1.18.3 Recent developments 296 17.1.18.3.1 Product launches 296 17.1.19 VISUS HEALTH IT GMBH 297 17.1.19.1 Business overview 297 17.1.19.2 Solutions offered 297   17.2 OTHER PLAYERS 298 17.2.1 ADVAHEALTH SOLUTIONS 298 17.2.2 SOFTTEAM SOLUTIONS PVT. LTD. 299 17.2.3 ARO SYSTEMS 299 17.2.4 CENTRAL DATA NETWORKS 300 17.2.5 ONEPACS 300 17.2.6 DEDALUS SPA. 301 18 RESEARCH METHODOLOGY 302 18.1 RESEARCH APPROACH 302 18.1.1 SECONDARY RESEARCH 302 18.1.1.1 Key data from secondary sources 303 18.1.2 PRIMARY RESEARCH 304 18.1.2.1 Primary sources 304 18.1.2.2 Key data from primary sources 305 18.1.2.3 Breakdown of primary interviews 306 18.1.2.4 Insights from primary experts 306 18.2 RESEARCH METHODOLOGY DESIGN 307 18.3 MARKET SIZE ESTIMATION 308 18.4 DATA TRIANGULATION 313 18.5 RESEARCH ASSUMPTIONS 314 18.6 RESEARCH LIMITATIONS 314 18.6.1 METHODOLOGY-RELATED 314 18.6.2 SCOPE-RELATED 315 18.7 RISK ASSESSMENT 315 19 APPENDIX 316 19.1 DISCUSSION GUIDE 316 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322 19.3 CUSTOMIZATION OPTIONS 324 19.4 RELATED REPORTS 324 19.5 AUTHOR DETAILS 325
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32 TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 53 TABLE 3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ROLE IN ECOSYSTEM 58 TABLE 4 AVERAGE SELLING PRICE OF PACS SOLUTIONS, BY PRODUCT TYPE (USD) 59 TABLE 5 AVERAGE SELLING PRICE OF VNA SOLUTIONS, BY PRODUCT TYPE (USD) 59 TABLE 6 KEY CONFERENCES AND EVENTS, 2026–2027 60 TABLE 7 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN TELEHEALTH & TELEMEDICINE 68 TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS, 2015–2025 70 TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 12 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF FOUR END USERS 78 TABLE 14 KEY BUYING CRITERIA FOR FOUR END USERS 79 TABLE 15 UNMET NEEDS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 80 TABLE 16 END-USER EXPECTATIONS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 81 TABLE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 84 TABLE 18 VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 85 TABLE 19 VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 85 TABLE 20 DEPARTMENT VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 87 TABLE 21 MULTI-DEPARTMENT VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 88 TABLE 22 MULTI-SITE VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 90 TABLE 23 PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 91 TABLE 24 PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 91 TABLE 25 DEPARTMENT PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 93 TABLE 26 MULTI-DEPARTMENT PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 94 TABLE 27 MULTI-SITE PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 96 TABLE 28 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 98 TABLE 29 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR CT, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 99 TABLE 30 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR MAMMOGRAPHY, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 101 TABLE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ULTRASOUND, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 102 TABLE 32 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY/REGION, 2024–2031 (USD MILLION) 104 TABLE 33 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR X-RAY, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 105 TABLE 34 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 107 TABLE 35 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 109 TABLE 36 ON-PREMISE VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 110 TABLE 37 CLOUD-BASED VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 112 TABLE 38 HYBRID VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 113 TABLE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 115 TABLE 40 INDEPENDENT VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 116 TABLE 41 THIRD-PARTY VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 118 TABLE 42 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 120 TABLE 43 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 121 TABLE 44 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 123 TABLE 45 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ONCOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 124 TABLE 46 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 126 TABLE 47 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OBSTETRICS AND GYNECOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 127 TABLE 48 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 129 TABLE 49 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 131 TABLE 50 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 132 TABLE 51 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 134 TABLE 52 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 135 TABLE 53 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 137 TABLE 54 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION, 2024–2031 (USD MILLION) 139 TABLE 55 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 140 TABLE 56 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 141 TABLE 57 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 141 TABLE 58 NORTH AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 141 TABLE 59 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 142 TABLE 60 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 142 TABLE 61 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 143 TABLE 62 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 143 TABLE 63 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 144 TABLE 64 US: KEY MACRO INDICATORS 145 TABLE 65 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 146 TABLE 66 US: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 146 TABLE 67 US: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 146 TABLE 68 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 147 TABLE 69 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 147 TABLE 70 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 147 TABLE 71 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 148 TABLE 72 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 148 TABLE 73 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 149 TABLE 74 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 149 TABLE 75 CANADA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 150 TABLE 76 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 150 TABLE 77 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 151 TABLE 78 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 151 TABLE 79 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 152 TABLE 80 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 152 TABLE 81 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 153 TABLE 82 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 153 TABLE 83 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 154 TABLE 84 EUROPE: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 154 TABLE 85 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 154 TABLE 86 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 155 TABLE 87 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 155 TABLE 88 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 156 TABLE 89 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 156 TABLE 90 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 158 TABLE 91 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 158 TABLE 92 GERMANY: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 158 TABLE 93 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 159 TABLE 94 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 159 TABLE 95 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 159 TABLE 96 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 160 TABLE 97 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 160 TABLE 98 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 162 TABLE 99 UK: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 162 TABLE 100 UK: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 162 TABLE 101 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 163 TABLE 102 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 163 TABLE 103 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 163 TABLE 104 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 164 TABLE 105 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 164 TABLE 106 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 165 TABLE 107 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 166 TABLE 108 FRANCE: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 166 TABLE 109 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 166 TABLE 110 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 167 TABLE 111 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 167 TABLE 112 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168 TABLE 113 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 168 TABLE 114 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 169 TABLE 115 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 169 TABLE 116 ITALY: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 170 TABLE 117 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 170 TABLE 118 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 171 TABLE 119 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 171 TABLE 120 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172 TABLE 121 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 172 TABLE 122 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 173 TABLE 123 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 173 TABLE 124 SPAIN: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 174 TABLE 125 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 174 TABLE 126 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 175 TABLE 127 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 175 TABLE 128 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 176 TABLE 129 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 176 TABLE 130 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 177 TABLE 131 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 177 TABLE 132 REST OF EUROPE: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 178 TABLE 133 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 178 TABLE 134 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 179 TABLE 135 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 179 TABLE 136 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 180 TABLE 137 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 180 TABLE 138 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 181 TABLE 139 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 181 TABLE 140 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 182 TABLE 141 ASIA PACIFIC: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 182 TABLE 142 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 182 TABLE 143 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 183 TABLE 144 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 183 TABLE 145 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 184 TABLE 146 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 184 TABLE 147 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 186 TABLE 148 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 186 TABLE 149 JAPAN: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 187 TABLE 150 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 187 TABLE 151 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 188 TABLE 152 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 188 TABLE 153 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 189 TABLE 154 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 189 TABLE 155 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 190 TABLE 156 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 190 TABLE 157 CHINA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 191 TABLE 158 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 191 TABLE 159 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 192 TABLE 160 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 192 TABLE 161 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 193 TABLE 162 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 193 TABLE 163 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 194 TABLE 164 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 195 TABLE 165 INDIA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 195 TABLE 166 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 195 TABLE 167 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 196 TABLE 168 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 196 TABLE 169 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197 TABLE 170 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 197 TABLE 171 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 198 TABLE 172 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 198 TABLE 173 REST OF ASIA PACIFIC: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 199 TABLE 174 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 199 TABLE 175 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 200 TABLE 176 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 200 TABLE 177 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 201 TABLE 178 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 201 TABLE 179 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 202 TABLE 180 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 202 TABLE 181 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 203 TABLE 182 LATIN AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 203 TABLE 183 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 204 TABLE 184 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 204 TABLE 185 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 204 TABLE 186 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205 TABLE 187 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 205 TABLE 188 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 206 TABLE 189 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 207 TABLE 190 BRAZIL: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 207 TABLE 191 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 208 TABLE 192 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 208 TABLE 193 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 208 TABLE 194 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 209 TABLE 195 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 209 TABLE 196 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 210 TABLE 197 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 210 TABLE 198 MEXICO: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 211 TABLE 199 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 211 TABLE 200 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 212 TABLE 201 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 212 TABLE 202 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 213 TABLE 203 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 213 TABLE 204 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 214 TABLE 205 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 214 TABLE 206 REST OF LATIN AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 215 TABLE 207 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 215 TABLE 208 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 216 TABLE 209 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 216 TABLE 210 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 217 TABLE 211 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 217 TABLE 212 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 218 TABLE 213 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 218 TABLE 214 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 219 TABLE 215 MIDDLE EAST & AFRICA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 219 TABLE 216 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 220 TABLE 217 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 220 TABLE 218 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 221 TABLE 219 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 221 TABLE 220 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 222 TABLE 221 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 223 TABLE 222 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 223 TABLE 223 GCC COUNTRIES: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 224 TABLE 224 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 224 TABLE 225 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 225 TABLE 226 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 225 TABLE 227 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 226 TABLE 228 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 226 TABLE 229 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 227 TABLE 230 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 227 TABLE 231 REST OF MIDDLE EAST AND AFRICA: PACS MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 228 TABLE 232 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024–2031 (USD MILLION) 228 TABLE 233 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 229 TABLE 234 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024–2031 (USD MILLION) 229 TABLE 235 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 230 TABLE 236 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024–2031 (USD MILLION) 230 TABLE 237 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, JANUARY 2023–APRIL 2026 232 TABLE 238 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEGREE OF COMPETITION 235 TABLE 239 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PRODUCT FOOTPRINT, 2025 240 TABLE 240 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEPLOYMENT FOOTPRINT, 2025 240 TABLE 241 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: END USER FOOTPRINT, 2025 241 TABLE 242 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: REGIONAL FOOTPRINT, 2025 242 TABLE 243 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 245 TABLE 244 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 245 TABLE 245 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–APRIL 2026 248 TABLE 246 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEALS, JANUARY 2023–APRIL 2026 249 TABLE 247 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 250 TABLE 248 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW 251 TABLE 249 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED 252 TABLE 250 AGFA-GEVAERT GROUP: DEALS 253 TABLE 251 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 255 TABLE 252 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 256 TABLE 253 FUJIFILM HOLDINGS CORPORATION: DEALS 257 TABLE 254 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS 258 TABLE 255 SECTRA AB: BUSINESS OVERVIEW 259 TABLE 256 SECTRA AB: SOLUTIONS OFFERED 260 TABLE 257 GE HEALTHCARE: BUSINESS OVERVIEW 263 TABLE 258 GE HEALTHCARE: SOLUTIONS OFFERED 264 TABLE 259 GE HEALTHCARE: PRODUCTS LAUNCHES 265 TABLE 260 GE HEALTHCARE: DEALS 266 TABLE 261 MERATIVE: BUSINESS OVERVIEW 268 TABLE 262 MERATIVE: SOLUTIONS OFFERED 268 TABLE 263 MERATIVE: DEALS 269 TABLE 264 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 271 TABLE 265 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 272 TABLE 266 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES 273 TABLE 267 KONINKLIJKE PHILIPS N.V.: DEALS 274 TABLE 268 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 275 TABLE 269 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED 276 TABLE 270 CANON MEDICAL SYSTEMS CORPORATION: DEALS 277 TABLE 271 PAXERAHEALTH: BUSINESS OVERVIEW 278 TABLE 272 PAXERAHEALTH: SOLUTIONS OFFERED 278 TABLE 273 NOVARAD CORPORATION: BUSINESS OVERVIEW 280 TABLE 274 NOVARAD CORPORATION: SOLUTIONS OFFERED 280 TABLE 275 HYLAND SOFTWARE, INC.: BUSINESS OVERVIEW 282 TABLE 276 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED 282 TABLE 277 HYLAND SOFTWARE, INC.: DEALS 283 TABLE 278 SIEMENS HEALTHCARE LIMITED: BUSINESS OVERVIEW 284 TABLE 279 SIEMENS HEALTHCARE LIMITED: SOLUTIONS OFFERED 285 TABLE 280 SIEMENS HEALTHCARE LIMITED: DEALS 286 TABLE 281 BRIDGEHEAD SOFTWARE LTD.: BUSINESS OVERVIEW 287 TABLE 282 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED 287 TABLE 283 CANOPY PARTNERS: BUSINESS OVERVIEW 288 TABLE 284 CANOPY PARTNERS: SOLUTIONS OFFERED 288 TABLE 285 CRELIOHEALTH INC.: BUSINESS OVERVIEW 289 TABLE 286 CRELIOHEALTH INC.: SOLUTIONS OFFERED 289 TABLE 287 ASPYRA, LLC: BUSINESS OVERVIEW 290 TABLE 288 ASPYRA, LLC: SOLUTIONS OFFERED 290 TABLE 289 POSTDICOM: BUSINESS OVERVIEW 292 TABLE 290 POSTDICOM: SOLUTIONS OFFERED 292 TABLE 291 MEDICASOFT: BUSINESS OVERVIEW 294 TABLE 292 MEDICASOFT: SOLUTIONS OFFERED 294 TABLE 293 ESAOTE SPA.: BUSINESS OVERVIEW 295 TABLE 294 ESAOTE SPA: SOLUTIONS OFFERED 295 TABLE 295 ESAOTE SPA: PRODUCT LAUNCHES 296 TABLE 296 VISUS HEALTH IT GMBH: BUSINESS OVERVIEW 297 TABLE 297 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED 297 FIGURE 1 STUDY YEARS CONSIDERED 32 FIGURE 2 MARKET SCENARIO 34 FIGURE 3 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2024–2031 USD MILLION) 35 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 35 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 36 FIGURE 6 HIGH-GROWTH SEGMENTS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 37 FIGURE 7 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 38 FIGURE 8 EXPANSION OF ENTERPRISE IMAGING & MULTI-SITE HEALTHCARE NETWORKS FUELING DEMAND IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 39 FIGURE 9 HOSPITALS & END USERS AND US ACCOUNTED FOR LARGEST RESPECTIVE SHARES IN 2025 40 FIGURE 10 INDIA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 41 FIGURE 11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42 FIGURE 12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PORTER’S FIVE FORCES ANALYSIS 52 FIGURE 13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: VALUE CHAIN ANALYSIS 55 FIGURE 14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ECOSYSTEM MAPPING 57 FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61 FIGURE 16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: INVESTMENT AND FUNDING SCENARIO, 2022–2025 (USD MILLION) 62 FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, JANUARY 2022–MAY 2025 68 FIGURE 18 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VNA AND PACS, JANUARY 2015 TO MAY 2025 69 FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF FOUR END USERS 78 FIGURE 20 KEY BUYING CRITERIA FOR FOUR END USERS 79 FIGURE 21 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT 140 FIGURE 22 UK: COUNT OF DIAGNOSTIC IMAGING ACTIVITY ON NHS PATIENTS, JANUARY 2022–JANUARY 2023 (MILLION) 161 FIGURE 23 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT 185 FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2021–2025 (USD MILLION) 234 FIGURE 25 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: MARKET SHARE ANALYSIS (2025) 235 FIGURE 26 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 238 FIGURE 27 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY FOOTPRINT, 2025 239 FIGURE 28 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 244 FIGURE 29 EV/EBITDA OF KEY VENDORS, 2026 246 FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS, 2026 246 FIGURE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 247 FIGURE 32 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT 252 FIGURE 33 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 256 FIGURE 34 SECTRA AB: COMPANY SNAPSHOT 260 FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT 264 FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 272 FIGURE 37 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 276 FIGURE 38 SIEMENS HEALTHCARE LIMITED: COMPANY SNAPSHOT 285 FIGURE 39 RESEARCH DESIGN 302 FIGURE 40 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 307 FIGURE 41 BOTTOM-UP APPROACH 308 FIGURE 42 TOP-DOWN APPROACH 309 FIGURE 43 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 310 FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 311 FIGURE 45 DATA TRIANGULATION 313

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們